LABORATORY RESEARCH
Research underway in OICR genomics lab
Equipment is humming, lab technicians are hard at work and cutting-edge research is underway at OICR’s new research facilities.
GO TO THIS STORY
GO TO BIO OF SENIOR PRINCIPAL INVESTIGATOR DR. JOHN McPHERSON
PUBLIC OUTREACH
OICR lecture series back for a second season
Dr. Francis Collins, Director of the National Human Genome Research Institute of the National Institutes of Health in the U.S., will speak at Toronto's MaRS Centre on October 2, 2007 at 6:30 p.m.
VIEW THE ENTIRE 2007-2008 PUBLIC LECTURE SCHEDULE (PRINTABLE PDF)
GENOMIC BREAKTHROUGH
Discovery could contribute to improved colorectal testing
OICR-led ARCTIC project links chromosome 8 to colon cancer.
GO TO THIS STORY
BREAST CANCER RESEARCH
Osteopontin could be key to new treatments
Dr. Ann Chambers is investigating osteopontin, a compound found in elevated levels in women who have breast cancer.
LIFETIME ACHIVEMENT
Understanding retinoblastoma, one eye at a time
Dr. Brenda Gallie has devoted her life to helping children with cancer.
LUNG CANCER RESEARCH
OICR enters lung cancer partnership with world-leading
research institutes
OICR has taken a major step into international research, joining some of the most important research institutions in the world on the first phase of a large-scale international study on lung cancer.
MEDICAL IMAGING
Dr. Aaron Fenster appointed to lead Imaging Pipeline Platform
Province-wide initiative will translate new imaging technologies into clinical applications.
ABOUT THE INSTITUTE
Meet OICR's Board of Directors
OICR's board brings together leaders in science, government, business and medicine.
OICR congratulates Dr. Calvin Stiller on receiving honorary degree
OICR Board member recognized by the University of Western Ontario for his tireless devotion to science, innovation and public service.
LABORATORY RESEARCH
Dr. Jason Moffat brings RNAi north
Ontario is building a library to help scientists better understand cancer, but rather than books, the catalogue is filled with a set of compounds that can shut down any individual gene using a scientific technique called ribonucleic acid interference, or RNAi.
MEDICAL IMAGING
Dr. Martin Yaffe accepts OICR's challenge to find one-millimetre tumours
Labs across Ontario will join forces to image tumours at the stage when they are most treatable.
TECHNOLOGY
OICR gearing up to store vast amounts of data
The Institute's Bioinformatics and Biocomputing Platform will build capacity to store millions of megabytes of scientific data.
Ontario Institute for
Cancer Research
MaRS Centre, South Tower
101 College Street, Suite 500
Toronto, Ontario
Canada M5G 0A3
1-866-678-6427
www.oicr.on.ca
Portal is a quarterly publication for stakeholders of the Ontario Institute for Cancer Research. We welcome your feedback, suggestions and comments.
Funding for the Ontario
Institute for Cancer Research
is provided by the
Government of Ontario